MDM2 promotor polymorphism and disease characteristics in CLL

被引：3
|
作者：
Zenz, Thorsten [1 ]
Benner, Axel [2 ]
Stilgenbauer, Stephan [1 ]
机构：
[1] Univ Ulm, Dept Internal Med 3, D-89081 Ulm, Germany
[2] German Canc Res Ctr, Div Biostat, D-6900 Heidelberg, Germany
来源：
LEUKEMIA RESEARCH | 2010年 / 34卷 / 05期
关键词：
MDM2; CLL; SNP; CHRONIC LYMPHOCYTIC-LEUKEMIA; SINGLE NUCLEOTIDE POLYMORPHISM; PATHWAY; SURVIVAL; PREDICTS; SNP309; CANCER; HUMANS;
D O I：
10.1016/j.leukres.2009.07.015
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：578 / 579
页数：2
相关论文
共 50 条
  • [1] Association of MDM2 SNP309 polymorphism and HBV infection in CLL
    Li, Yue
    Liang, Jin-Hua
    Qin, Shu-Chao
    Xia, Yi
    Wang, Li
    Fan, Lei
    Hu, Zhi-Bin
    Li, Jian-Yong
    Xu, Wei
    LEUKEMIA & LYMPHOMA, 2015, 56 : 50 - 51
  • [2] MDM2 promotor polymorphism and disease characteristics in chronic lymphocytic leukemia: results of an individual patient data-based meta-analysis
    Benner, Axel
    Mansouri, Larry
    Rossi, Davide
    Majid, Aneela
    Willander, Kerstin
    Parker, Anton
    Bond, Gareth
    Pavlova, Sarka
    Nueckel, Holger
    Merkel, Olaf
    Ghia, Paolo
    Montserrat, Emili
    Kaderi, Mohd Arifin
    Rosenquist, Richard
    Gaidano, Gianluca
    Dyer, Martin J. S.
    Soederkvist, Peter
    Linderholm, Mats
    Oscier, David
    Tvaruzkova, Zuzana
    Pospisilova, Sarka
    Duehrsen, Ulrich
    Greil, Richard
    Doehner, Hartmut
    Stilgenbauer, Stephan
    Zenz, Thorsten
    HAEMATOLOGICA, 2014, 99 (08) : 1285 - 1291
  • [3] Influence of MDM2 single nucleotide polymorphism SNP309 on disease onset and course in CLL.
    Zenz, Thorsten
    Habe, Sonja
    Buhler, Andreas
    Krober, Alexander
    Denzel, Tina
    Dohner, Hartmut
    Stilgqnbauer, Stephan
    BLOOD, 2006, 108 (11) : 321B - 322B
  • [4] Impact of MDM2 gene polymorphism on sarcoma risk
    Zhang, Dawei
    Ding, Yuanyuan
    Wang, Zhenlin
    Wang, Yan
    Zhao, Guangyue
    TUMOR BIOLOGY, 2015, 36 (03) : 1791 - 1795
  • [5] MDM2 309 polymorphism is associated with missed abortion
    Fang, Yan
    Kong, Beihua
    Yang, Qifeng
    Ma, Daoxin
    Qu, Xun
    HUMAN REPRODUCTION, 2009, 24 (06) : 1346 - 1349
  • [6] A TRANSCRIBED POLYMORPHISM AND SUB-LOCALIZATION OF MDM2
    HEIGHWAY, J
    MITCHELL, ELD
    JONES, D
    WHITE, GRM
    KOREF, MFS
    HUMAN GENETICS, 1994, 93 (05) : 611 - 612
  • [7] MDM2 gene polymorphism and endometrial cancer risk
    Zajac, Agnieszka
    Pertynski, Tomasz
    PRZEGLAD MENOPAUZALNY, 2009, 8 (05): : 269 - 272
  • [8] INFERIOR OVERALL SURVIVAL IN CLL PATIENTS WITH TP53 MUTATIONS AND MDM2 SNP309 POLYMORPHISM
    Linderholm, R. H.
    Willander, K.
    Karlsson, K.
    Soderkvist, P.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 213 - 214
  • [9] A single nucleotide polymorphism in the MDM2 gene disrupts the oscillation of p53 and MDM2 levels in cells
    Hu, Wenwei
    Feng, Zhaohui
    Ma, Lan
    Wagner, John
    Rice, J. Jeremy
    Stolovitzky, Gustavo
    Levine, Arnold J.
    CANCER RESEARCH, 2007, 67 (06) : 2757 - 2765
  • [10] MDM2-SNP 309 allele status does not affect sensitivity to MDM2 inhibitors in CLL
    Malek, Sami N.
    BLOOD, 2008, 112 (05) : 2169 - 2169
12345